Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Citrulline peptides derived from fibrin and recognized by rheumatoid arthritis specific autoantibodies, and the use thereof

Citrulline peptides derived from fibrin and recognized by rheumatoid arthritis specific autoantibodies, and the use thereof

US Patent 8207299 · Granted Jun 26, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Polypeptide expressed in the stratum corneum and use thereof2022
Polypeptide expressed in the stratum corneum and use thereof2017
Peptidyl arginine deiminase 1 and/or 3 activator compounds in the epidermis and 2017
Peptides modulating the activity of macrophages, useable for the treatment of rh2016
Peptides modulating the activity of macrophages, useable for the treatment of rh2016
Citrulline peptides derived from fibrin and recognized by rheumatoid arthritis s2016
Citrulline peptides derived from fibrin and recognized by rheumatoid arthritis s2016
Polypeptide expressed in the stratum corneum and thereof2015
Method for detecting rheumatoid arthritis-specific autoantibodies2012
Method for detecting rheumatoid arthritis-specific autoantibodies2012
Fibrin citrulline derivatives and their use for diagnosing or treating rheumatoi2008
Fibrin citrulline derivatives and their use for diagnosing or treating rheumatoi2008